A detailed history of Principal Financial Group Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 2,377,403 shares of ZTS stock, worth $421 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,377,403
Previous 2,026,031 17.34%
Holding current value
$421 Million
Previous $351 Million 32.25%
% of portfolio
0.27%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$172.58 - $196.48 $60.6 Million - $69 Million
351,372 Added 17.34%
2,377,403 $464 Million
Q2 2024

Jul 29, 2024

BUY
$145.54 - $178.83 $18.1 Million - $22.3 Million
124,547 Added 6.55%
2,026,031 $351 Million
Q1 2024

Apr 29, 2024

SELL
$165.67 - $199.94 $12.3 Million - $14.9 Million
-74,513 Reduced 3.77%
1,901,484 $322 Million
Q4 2023

Feb 07, 2024

SELL
$151.44 - $200.09 $22.7 Million - $30 Million
-150,093 Reduced 7.06%
1,975,997 $390 Million
Q3 2023

Nov 02, 2023

BUY
$167.14 - $192.77 $1.7 Million - $1.96 Million
10,153 Added 0.48%
2,126,090 $370 Million
Q2 2023

Aug 07, 2023

SELL
$160.94 - $186.23 $19.3 Million - $22.3 Million
-119,926 Reduced 5.36%
2,115,937 $364 Million
Q1 2023

May 09, 2023

SELL
$145.48 - $175.02 $2.24 Million - $2.69 Million
-15,392 Reduced 0.68%
2,235,863 $372 Million
Q4 2022

Feb 09, 2023

BUY
$131.14 - $157.47 $9.62 Million - $11.5 Million
73,322 Added 3.37%
2,251,255 $330 Million
Q3 2022

Nov 09, 2022

BUY
$148.29 - $182.55 $33.4 Million - $41.2 Million
225,510 Added 11.55%
2,177,933 $323 Million
Q2 2022

Aug 10, 2022

BUY
$155.97 - $200.09 $54.5 Million - $69.9 Million
349,478 Added 21.8%
1,952,423 $336 Million
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $64.3 Million - $82.9 Million
354,224 Added 28.37%
1,602,945 $302 Million
Q4 2021

Feb 09, 2022

BUY
$193.69 - $247.03 $4.86 Million - $6.2 Million
25,092 Added 2.05%
1,248,721 $303 Million
Q3 2021

Nov 09, 2021

BUY
$189.29 - $209.69 $5.38 Million - $5.96 Million
28,430 Added 2.38%
1,223,629 $238 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $3.22 Million - $3.88 Million
20,661 Added 1.76%
1,195,199 $223 Million
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $77.7 Million - $91.4 Million
539,555 Added 84.97%
1,174,538 $185 Million
Q4 2020

Feb 08, 2021

SELL
$157.07 - $174.35 $5.1 Million - $5.66 Million
-32,456 Reduced 4.86%
634,983 $105 Million
Q3 2020

Nov 06, 2020

SELL
$137.1 - $165.37 $6.29 Million - $7.59 Million
-45,895 Reduced 6.43%
667,439 $110 Million
Q2 2020

Aug 05, 2020

BUY
$111.92 - $142.53 $4.3 Million - $5.47 Million
38,400 Added 5.69%
713,334 $97.8 Million
Q1 2020

May 12, 2020

BUY
$92.66 - $144.94 $60,414 - $94,500
652 Added 0.1%
674,934 $79.4 Million
Q4 2019

Feb 05, 2020

SELL
$116.25 - $133.25 $2.38 Million - $2.73 Million
-20,498 Reduced 2.95%
674,282 $89.2 Million
Q3 2019

Nov 13, 2019

SELL
$112.57 - $128.43 $958,308 - $1.09 Million
-8,513 Reduced 1.21%
694,780 $86.6 Million
Q2 2019

Aug 12, 2019

BUY
$97.98 - $114.28 $434,051 - $506,260
4,430 Added 0.63%
703,293 $79.8 Million
Q1 2019

May 10, 2019

SELL
$81.56 - $100.67 $13.3 Million - $16.4 Million
-162,510 Reduced 18.87%
698,863 $70.4 Million
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $5.14 Million - $6.17 Million
-64,805 Reduced 7.0%
861,373 $73.7 Million
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $3.91 Million - $4.36 Million
-46,772 Reduced 4.81%
926,178 $84.8 Million
Q2 2018

Aug 13, 2018

BUY
$79.9 - $89.2 $15.7 Million - $17.5 Million
196,450 Added 25.3%
972,950 $0
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $746,993 - $884,671
10,446 Added 1.36%
776,500 $64.8 Million
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $1.78 Million - $2.05 Million
28,200 Added 3.82%
766,054 $55.2 Million
Q3 2017

Nov 02, 2017

BUY
$59.73 - $65.4 $44.1 Million - $48.3 Million
737,854
737,854 $47 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.